Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial

Anti-migraine and anti-depression activities of Tianshu capsule by mediating Monoamine oxidase

(2018) Xiaoping Sun et al.   BIOMEDICINE & PHARMACOTHERAPY

Migraine is first cause of disability in under 50s: will health politicians now take notice?

(2018) Timothy J. Steiner et al.   JOURNAL OF HEADACHE AND PAIN

Simultaneous determination of ferulic acid and gastrodin of Tianshu Capsule in rat plasma by ultra-fast liquid chromatography with tandem mass spectrometry and its application to a comparative pharmacokinetic study in normal and migraine rats

(2017) Jiao Guan et al.   JOURNAL OF SEPARATION SCIENCE

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2017) Theo Vos et al.   LANCET

Prophylactic Drug Treatment of Migraine in Children and Adolescents: An Update

(2015) János Tajti et al.   Current Pain and Headache Reports

Drug safety and tolerability in prophylactic migraine treatment

(2015) László Vécsei et al.   Expert Opinion On Drug Safety

Systems pharmacology to decipher the combinational anti-migraine effects of Tianshu formula

(2015) Yan Li et al.   JOURNAL OF ETHNOPHARMACOLOGY

Publication committees in clinical trials in headache

(2011) Peer Carsten Tfelt-Hansen et al.   CEPHALALGIA

The Prevalence and Burden of Primary Headaches in China: A Population-Based Door-to-Door Survey

(2011) Shengyuan Yu et al.   HEADACHE